GlassScriptPhysician profile
Eric H Elowitz
NPI 1780666735
$35,904.63
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $11K · 2021: $4,591.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Joimax, INC. | $27,420.44 | 2019-2020 | |
| Medtronic, INC. | $4,030.60 | 2021 | |
| Medtronic USA, INC. | $3,026.99 | 2019-2020 | |
| Alphatec Spine, INC | $589.71 | 2020-2021 | |
| Brainlab, INC. | $500.00 | 2019 | |
| Viseon, INC. | $139.13 | 2021 | |
| Nuvasive, INC. | $101.22 | 2019 | |
| Intrinsic Therapeutics | $96.54 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$2,430,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Elowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.